We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Collaborators to Develop Smart Consumables for a Novel Label-Free Biological Imaging System

By LabMedica International staff writers
Posted on 19 Dec 2011
A newly reported collaboration brings together the manufacturer of a novel system for biological image analysis and a large international developer and marketer of dedicated consumable products.

Maven Biotechnologies (Monrovia, CA, USA), manufacturer of the Label-Free Internal Reflection Ellipsometry (LFIRE) image analysis system has formally announced the establishment of a collaborative agreement with Sony DADC BioSciences (Salzburg, Austria), the biotech component of the international conglomerate Sony.

The basis of LFIRE is ellipsometry, a technique that measures changes in the polarization of light upon reflection from the interface between materials. More...
This measurement provides optical properties of thin layers of materials at the interface, namely the thickness or mass. Capable of detecting atom-scale changes in thickness or mass, ellipsometry is well established in the semiconductor industry for quality control analysis of silicon wafers.

LFIRE allows for the precise, real-time measurements of specific interactions between molecular entities in a microarray or well-plate format. These molecular entities can be proteins, nucleic acids, lipids, small molecules such as drugs or steroids, or even whole cells. As a “label-free” detection system, it avoids alterations of the molecules from the labeling procedures used in fluorescent systems and directly reduces labor and materials costs associated with tagging. As a “real-time” system, it monitors reactions as they happen, providing information about a sample before and after equilibrium. This additional information is necessary for increasing the dynamic range of concentration measurements, optimizing biological assays, and analyzing kinetic activity critical to drug research.

Sony intends to boost the market for the LFIRE system by contributing its experience in high-precision manufacturing as well as its mass production capability and supply chain expertise.

“The collaboration with Maven provides a perfect example of how we can translate our experience in microstructured engineering, gained through our pioneering optical disc work, to the needs of the life sciences industry,” said Dr. Ali Tinazli, a director of business development and sales at Sony DADC. “We are particularly pleased to work with Maven at such an early stage, which ensures solutions that will be scalable and traceable, to smooth the way to future regulatory approvals in the clinical space. The product is an advanced polymer slide that can be produced in mass quantities and still guarantee high optical quality.”

Jeffrey Chongsathien, chief engineering officer at Maven Biotechnologies, said, “We are excited to be working with Sony DADC to develop innovative consumables for our LFIRE platform. With Sony DADC's expertise in creating highly scalable and sophisticated optical media, we ensure that our customers will receive the maximum benefits of using LFIRE technology and at a lower cost per data point.”

Related Links:
Maven Biotechnologies
Sony DADC BioSciences




Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.